271 related articles for article (PubMed ID: 25066792)
1. Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study.
Harrow M; Jobe TH; Faull RN
Psychol Med; 2014 Oct; 44(14):3007-16. PubMed ID: 25066792
[TBL] [Abstract][Full Text] [Related]
2. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study.
Harrow M; Jobe TH; Faull RN
Psychol Med; 2012 Oct; 42(10):2145-55. PubMed ID: 22340278
[TBL] [Abstract][Full Text] [Related]
3. A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.
Harrow M; Jobe TH; Faull RN; Yang J
Psychiatry Res; 2017 Oct; 256():267-274. PubMed ID: 28651219
[TBL] [Abstract][Full Text] [Related]
4. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
5. Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.
Pathak S; Jiang Y; DiPetrillo L; Todtenkopf MS; Liu Y; Correll CU
J Clin Psychiatry; 2020 Mar; 81(2):. PubMed ID: 32220153
[TBL] [Abstract][Full Text] [Related]
6. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
7. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
8. Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up.
Gotfredsen DR; Wils RS; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AAE; Mors O; Nordentoft M
Psychol Med; 2017 Sep; 47(12):2118-2129. PubMed ID: 28382874
[TBL] [Abstract][Full Text] [Related]
9. Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders.
Harrow M; Jobe TH; Tong L
Psychol Med; 2022 Oct; 52(13):2681-2691. PubMed ID: 33550993
[TBL] [Abstract][Full Text] [Related]
10. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Oculogyric Crisis and Long-Term Outcomes With Second-Generation Antipsychotics in a First-Episode Psychosis Program.
Gardner DM; Abidi S; Ursuliak Z; Morrison J; Teehan MD; Tibbo PG
J Clin Psychopharmacol; 2015 Dec; 35(6):715-8. PubMed ID: 26485339
[TBL] [Abstract][Full Text] [Related]
12. The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disorders.
Mizrahi R; Kiang M; Mamo DC; Arenovich T; Bagby RM; Zipursky RB; Kapur S
Schizophr Res; 2006 Dec; 88(1-3):111-8. PubMed ID: 16956747
[TBL] [Abstract][Full Text] [Related]
13. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
Novak Sarotar B; Pesek MB; Agius M; Kocmur M
Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
[TBL] [Abstract][Full Text] [Related]
14. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
15. Choosing antipsychotic maintenance therapy--a naturalistic study.
Tavcar R; Dernovsek MZ; Zvan V
Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
17. Use of antipsychotics - an analysis of lifetime treatment in 66 patients with psychoses.
Jönsson EG; Saetre P; Vares M; Strålin P; Levander S; Lindström E
Psychiatry Res; 2011 May; 187(1-2):80-8. PubMed ID: 21095015
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients.
Herbener ES; Harrow M
Schizophr Bull; 2001; 27(3):527-37. PubMed ID: 11596853
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic medications in children and adolescents.
Findling RL; Grcevich SJ; Lopez I; Schulz SC
J Clin Psychiatry; 1996; 57 Suppl 9():19-23. PubMed ID: 8823346
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute psychosis without neuroleptics: two-year outcomes from the Soteria project.
Bola JR; Mosher LR
J Nerv Ment Dis; 2003 Apr; 191(4):219-29. PubMed ID: 12695732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
